Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in VLBW Infants Using Quantitative NIRS
NCT ID: NCT00544375
Last Updated: 2022-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2002-06-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
NCT01982357
Noninvasive Optical Measurement of Critical Care Neonates
NCT01483703
Photo-Plethysmographic Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants
NCT00989859
Application of Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants
NCT05961670
A Pilot Study Using Photo-plethysmographic (PPG) Camera
NCT01166867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
NIRS measurements of hemoglobin and hemoglobin saturation in tissues before and after red-cell transfusions in VLBW infants will determine the true effect of the transfusions, and develop more substantial guidelines regarding indications for transfusion. The accuracy of conventional (invasive) measurements of Hb and Hct could be comparison with results from the NIRS technique and clinical usefulness of the NIRS technique could be evaluated by comparison with trends in conventionally measured values taking fluid status into account.
Near-infrared light does not ionize biological tissue and poses no significant health risk. Since water absorption is low within this spectral range, local heating of the tissue is also minimal. Burns and heat damage to the neonate are highly unlikely.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neonatal Tissues
Optical measurement neonatal tissues
Optical measurement
Optical measurement neonatal tissues
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical measurement
Optical measurement neonatal tissues
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infants receiving at least one packed red blood cell transfusion
Exclusion Criteria
1 Minute
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Feizal Waffarn, M.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feizal Waffarn, M.D
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute University of California Irvine
Bruce Tromberg, PhD
Role: STUDY_DIRECTOR
Beckman Laser Institute University of California Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neonatal Intensive Care Unit, University of California Irvine
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20012011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.